Characteristics | N = 55 |
---|---|
Age (median, range) (years) | 55 (30–77) |
Gender | |
 Male | 31 (56.4%) |
 Female | 24 (43.6%) |
Diagnosis (WHO 2010) | |
 Tubular adenocarcinoma | 50 (90.9%) |
 Mucinous adenocarcinoma | 4 (7.3%) |
 Poorly cohesive carcinoma (Signet ring cell carcinoma) | 1 (1.8%) |
WHO grade | |
 Well differentiated | 0 (0.0%) |
 Moderated differentiated | 20 (36.4%) |
 Poorly differentiated | 34 (61.8%) |
 Undifferentiated | 1 (1.8%) |
Lauren classification | |
 Intestinal | 19 (34.5%) |
 Diffuse | 36 (65.5%) |
 Lymphatic invasion | 43 (78.2%) |
 Perineural invasion | 46 (83.6%) |
 Venous invasion | 15 (27.3%) |
 Microsatellite instability high | 6 (10.9%) |
 EBV infection | 4 (7.3%) |
Stage (AJCC 7th) | |
 II | 14 (25.5%) |
 III | 41 (74.5%) |
Disease progression | 23 (41.8%) |
Death | 21 (38.2%) |
PFS (months) (median, range) | 65.4 (4.0–102.9) |
OS (months) (median, range) | 85.4 (13.3–107.9) |